We conducted a series of polymerase chain reactions (PCRs) in order to detect bacteria (7 species) and viruses (17 species) in middle ear fluid (MEF) and nasopharynx (Nph) of children with acute otitis media (AOM; n = 179). Bacterial and viral nucleic acids were detected in MEF of 78.8% and 14.5% patients, respectively. The prevalence was as follows: Streptococcus pneumoniae, 70.4%; Haemophilus influenzae, 17.9%; Staphylococcus aureus, 16.8%; Streptococcus pyogenes, 12.3%; Moraxella catarrhalis, 9.5%; rhinovirus, 9.5%; and adenovirus, 3.4%. The overall rate of PCR-positive specimens for bacterial pathogens was 2.6 times higher, compared to culture results. The rate of PCR-positive results and the distribution of pathogens in the Nph were similar to those in the MEF. Nph PCR results had variable positive predictive values and high negative predictive values in predicting MEF findings.
Introduction
Acute otitis media (AOM) is one of the most common pediatric infections with high rate of medical visits and antibiotic prescriptions (Lieberthal et al., 2013) . Bacterial species, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes, predominate among AOM pathogens, being responsible for 80-90% of etiologically verified cases (Vergison, 2008) . Respiratory viruses like human rhinovirus (hRV), adenovirus (AdV), respiratory syncytial virus (RSV), and some others are occasionally found in the middle ear; however, their role as independent (primary) AOMcausing agents remains under discussion (Chonmaitree et al., 2012; Heikkinen and Chonmaitree, 2003; Nokso-Koivisto et al., 2015; Pitkäranta et al., 1998; Ruohola et al., 2006; Vergison, 2008) . Nevertheless, pathogenesis of AOM in children is clearly related to acute respiratory viral infections (ARVI) that, by various means, facilitate translocation of pathogen-containing secretions from inflamed nasopharynx into the middle ear (Lieberthal et al., 2013) . In many cases, ARVI precede AOM, and the latter is considered as a complication of ARVI (Chonmaitree et al., 2008) .
Traditionally, bacterial or viral culturing of the middle ear fluid (MEF) has been used for establishing etiology of AOM ensuring a 30-80% positive rate (Chonmaitree, 2000; Lieberthal et al., 2013) . Cultural analysis depends on viable microorganisms; it has limited sensitivity and is laborious and time consuming. Principal bacterial otopathogens, S. pneumoniae and H. influenzae, belong to fastidious microorganisms with special demands for plating time and culture medium that may preclude the proper isolation of these species (Ueyama et al., 1995) . The advent of molecular methods like PCR has increased the prevalence of positive MEF findings for bacterial pathogens and placed several new viruses among potential AOM pathogens (Bulut et al., 2007; Nokso-Koivisto et al., 2004; Pitkäranta et al., 1998; Ruohola et al., 2006; Ueyama et al., 1995; Williams et al., 2006; Yano et al., 2009) .
Systematic use of tympanocentesis is not advocated in the current clinical practice (Lieberthal et al., 2013) . This restricts availability of MEF for monitoring etiology of nonperforated AOM and implies Nph secretions as a potential proxy for MEF. Indeed, middle ear and nasopharynx findings have been compared in a number of studies, which indicated potential usefulness of nasopharynx examination (Radzikowski et al., 2011; van Dongen et al., 2013 and references therein) . Most of the studies employed PCR only for virus detection using culturing for bacterial isolation and identification.
In the present work, we used a series of multiplex real-time PCRs for detecting 7 bacterial and 17 viral species in MEF of children with AOM Diagnostic Microbiology and Infectious Disease 85 (2016) 125-130 and compared PCR results with culturing for selected bacterial pathogens. Moreover, we assessed the value of PCR findings in the nasopharynx for prediction of the pathogen presence in MEF during AOM.
Materials and methods

Study population and clinical specimens
This retrospective study was performed using biological specimens obtained from children below 5 years of age with AOM between August 2011 and April 2013 in 4 pediatric hospitals in Moscow, Russia, and included children who were diagnosed with AOM by an otolaryngologist and had an MEF specimen obtained from them (Mayanskiy et al., 2015) . A diagnosis of AOM was defined by otolaryngologists when a patient had acute illness lasting ≤7 days with signs and physical symptoms consistent with AOM, including earache, tugging at the ear, fever, redness, and bulging of tympanum. Patients who received an antibiotic prior to enrollment or had spontaneous tympanum perforation were excluded from the present study. MEF specimens were collected by otolaryngologists after tympanocentesis and swabbing the tympanic cavity with an eSWAB kit (Copan, Italy). This procedure was performed after removal of debris and cleaning of external auditory canal (lidocaine solution with ethyl alcohol, exposure for 1 minute). Each patient contributed 1 AOM case to the study. In bilateral AOM cases, MEF specimens were obtained from both ears. At the same visit, Nph swabs were collected by means of the eSWAB kit.
Biological samples and all data were collected according to the guidelines of the hospitals' ethics committee.
All specimens were delivered to the laboratory at the Scientific Center for Children's Health (Moscow) and processed there within 24-48 hours after sampling; before cultural analyses, the specimens were stored at room temperature in a dark place. Bacterial pathogens including S. pneumoniae, H. influenzae, M. catarrhalis, S. pyogenes, and Staphylococcus aureus were cultured and identified as described earlier (Mayanskiy et al., 2015) . A specimen was regarded culture positive if either of these bacteria alone or in combination was isolated.
PCR for bacterial and viral respiratory pathogens
The remaining specimens were frozen and stored at −70°C for further use in molecular assays that were performed in 2014 at the Central Research Institute for Epidemiology, Moscow, Russia, using reagent kits manufactured at this same institution (Supplement). All kits are cleared for in vitro diagnostic purposes. Total DNA and RNA were extracted from a 100-μL aliquot using the RIBO-prep nucleic acid extraction kit and eluted into the same volume of an elution buffer. cDNA was prepared by reverse transcription of 30 μL of RNA with the REVERTA-L RT kit. For PCRs, 10 μL of DNA or cDNA was used. Realtime PCR was utilized for detecting bacterial and viral nucleic acids (NAs) on a Rotor-Gene 6000 instrument (Corbett Research, Sydney, Australia). DNA from S. pneumoniae, H. influenzae, S. pyogenes, S. aureus, and M. catarrhalis was detected in a quantitative manner. S. pyogenes and S. aureus were analyzed using the AmpliSens® Streptococcus pyogenes-screen-titre-FRT PCR kit and the AmpliSens® MRSA-screen-titre-FRT PCR kit, respectively. For detection of the remaining bacteria, we used the S. pneumoniae Spn9802 gene fragment (Abdeldaim et al., 2010) , the H. influenzae hpd gene (Theodore et al., 2012) , and the M. catarrhalis copB gene (Greiner et al., 2003) . Analytical sensitivity of these reactions was at least 5 copies of DNA per PCR (or 500 copies/mL) for every target (see Supplement for details). A real-time PCR result was considered positive when ≥1000 or 3 lg copies/mL of DNA were found.
NAs from the rest of respiratory pathogens were detected in a qualitative manner. Identification of the Mycoplasma pneumoniae and Chlamydophila pneumoniae DNA was done by the AmpliSens M. pneumoniae/C. pneumoniae-FRT PCR kit. Viral NA identification included influenza viruses A and B (using the AmpliSens Influenza virus A/B-FRT PCR kit); enterovirus (using the AmpliSens Enterovirus-FRT PCR kit); RSV, types A and B; human metapneumovirus; parainfluenzavirus, types 1-4; coronavirus ОС43, Е229, NL63, and HKU1; hRV; AdV, types B, C, and E; and human bocavirus (all using the AmpliSens ARVI-screen-FRT PCR kit). The Influenza virus C HE gene was detected by a 2-step real-time RT-PCR (see Supplement for details). Analytical sensitivity of each viral NA PCR test was at least 10 copies of DNA/cDNA per PCR (or 1000 copies/mL) for every target.
Statistics
The statistical analysis was performed using IBM SPSS Statistics for Windows, version 18.0 (IBM, Armonk, NY, USA). DNA load in different specimens was compared by the Mann-Whitney test that was considered statistically significant at P b 0.05. Sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) of an Nph PCR result in predicting the presence of NA from a particular respiratory pathogen in MEF were calculated using an MEF specimen PCR result as the reference. Cramer's V test was used as a measure of strength of association between PCR results in MEF and nasopharynx for a particular pathogen. This test may have values from 0 to 1; higher values indicate a stronger association (Grjibovski, 2008) .
Results
PCR analysis of MEF specimens
PCR was performed in a total of 216 MEF specimens obtained from 179 children with AOM (142 patients had unilateral AOM; 37 patients had bilateral AOM, each contributed an MEF specimen from both ears); the median patient age was 30 months (range, 1 month to 5 years). The NA from at least 1 pathogen under study (e.g., PCRpositive results) was discovered in 93.3% (167/179) children. Overall, the bacterial pathogen DNA alone had 78.8% (141/179) patients. DNA from a single species was found in 54.2% (97/179) patients, whereas DNA from 2 species was found in 20.1% (36/179) patients, and 4.5% (8/179) children had DNA from 3 to 4 species.
The most prevalent organism among pathogens under study was S. pneumoniae; the pneumococcal DNA was found in 70.4% (126/179) patients (Table 1) . A noticeable prevalence was found for the S. aureus DNA, which was detected in 16.8% (30/179) patients. However, the S. aureus DNA was always present in a combination with NA from other pathogens, and no patients had the S. aureus DNA alone in the MEF (Table 1) . This was in contrast with, for instance, the pneumococcal DNA that was the only NA found in 58% (73/126) S. pneumoniae DNApositive patients. DNA from M. pneumoniae or C. pneumoniae was not found in MEF of any patient.
In paired MEF specimens obtained from children with bilateral AOM (n = 37), PCR results almost completely agreed. Only in 3 patients DNA from H. influenzae (n = 1), RNA from hRV (n = 1), and a mixture of NA from S. aureus and hRV (n = 1) was discovered in 1 ear in addition to the S. pneumoniae DNA found in both ears.
Viral NA was present in 14.5% (26/179) children, although only 2.2% (4/179) patients had viral NA alone that represented hRV (n = 3) and AdV (n = 1) ( Table 1) . A mixture of bacterial and viral NA was observed in 12.3% (22/179) children. The highest discovery rate was registered for the hRV RNA and the AdV DNA that were detected in MEF of 9.5% (17/179) and 3.4% (6/179) children, respectively (Table 1 ). NA from RSV; influenza virus, type C; and human bocavirus were found rarely (each in 1 or 2 patients) and exclusively in combination with DNA from a bacterial pathogen. No NA from influenza virus, types A and B; parainfluenzavirus; human metapneumovirus; enterovirus; and coronavirus was found in the MEF.
Comparison of PCR and culturing for detection of bacterial pathogens in the MEF
Next, we compared PCR and culturing results of bacterial pathogens considering the specimen level (Table 2) . Bacterial DNA was found in 91.7% (198/216) MEF specimens, whereas culture-positive results were observed in 35.7% (77/216) specimens. Thus, the overall rate of PCR-positive specimens for bacterial pathogens was 2.6 times higher (95% confidential interval [CI] 2.3-3.0 times).
The difference in the detection rate between PCR and culturing had a pathogen-specific manner. The biggest gap was observed for H. influenzae that was found 10 times (95% CI 6.5-138 times) more often by PCR than by culturing. For the rest of bacterial pathogens under study, the ratio of PCR-positive/culture-positive specimens varied between 2 and 5.1 ( Table 2) .
The overall median DNA load in culture-positive/PCR-positive MEF specimens was close to 6 lg copies/mL for all bacterial pathogens except M. catarrhalis, which had a median DNA load of 4.83 lg copies/mL ( Table 2 ). The median DNA concentration of S. pneumoniae, S. pyogenes, and S. aureus was significantly higher (at least 1 lg copies/mL, i.e., 10 times) in culture-positive/PCR-positive specimens. In culture-positive specimens, the minimum load of the S. aureus DNA was 4.89 lg copies/mL; this value was 1-1.5 lg copies/mL higher comparing to the other bacteria (Table 2) .
3.3. The value of Nph PCR results in predicting the presence of a pathogen in the middle ear A Nph specimen was obtained from all patients enrolled to the study (n = 179). The overall rate of PCR-positive Nph specimens was 91.6% (164/179). Bacterial DNA was detected in 69.3% (124/179) specimens. In 1 patient, the M. pneumoniae DNA was detected in association with DNA from S. pneumoniae. None of the patients carried DNA from C. pneumoniae in the nasopharynx. The median load of DNA in Nph and MEF specimens was similar for all bacterial pathogens except M. catarrhalis that was approximately 1 lg copies/mL more abundant in the nasopharynx (Table 4 ). Viruses were detected in 22.3% (40/ 179) Nph specimens. The highest prevalence was found for hRV (8.9%) and AdV (5%) ( Table 3) . NAs from influenza virus В, metapneumovirus, coronavirus, and enterovirus were not detected in the nasopharynx.
The strength of agreement between PCR results in paired MEF and Nph specimens was assessed using the Cramer's V test (Grjibovski, 2008) . A strong association between MEF and Nph PCR results (V N 0.6) was observed for S. pneumoniae, H. influenzae, and AdV (Table 3 ). The remaining microorganisms demonstrated a substantial proportion of discordant PCR results, having lower V-values (Table 3) .
Next, we analyzed predictive value of Nph PCR results for the presence of NA from a certain microorganism in the MEF. A positive Nph PCR result had modest to low PPV, except for S. pneumoniae. Recovering the pneumococcal DNA in the nasopharynx increased a chance of positive PCR result for the pneumococcal DNA in the MEF up to 92% (PPV, Table 3 ). The lowest V-value and PPV were obtained for M. catarrhalis (0.33 and 32%, respectively) and S. aureus (0.42 and 46%, respectively).
The specificity and NPV of Nph PCR findings were high (Table 3) . For instance, the NPV of a negative Nph result for the pneumococcal DNA was 79%. This indicated that a chance of finding this DNA in the MEF was reduced from 70.4% (a value corresponding to the prevalence in MEF; see Table 1 ) to 21% (i.e., 100% − NPV), if it was not present in the nasopharynx.
Discussion
Etiology of AOM
In the present study, we performed PCR analysis for a broad range of respiratory pathogens in MEF and Nph specimens obtained from children with AOM. To our knowledge, this is the first comprehensive 
The sum of overall proportions of pathogens exceeded 100% because, in some patients, a combination of 2-4 pathogens was recovered. AdV = adenovirus (including types B, C, and E); InfC = influenza virus, type C; HBoV = human bocavirus; RSV = respiratory syncytial virus (including types A and B). a Each value in boldface indicates the number of patients with a corresponding pathogen detected singly in the MEF; the percentages (in brackets) represent a ratio of singly detected pathogen to the overall prevalence of this pathogen. study enrolling a significant number of patients that elaborates on etiology of AOM, using parallel PCR in the MEF and nasopharynx. Comparison of PCR with culturing demonstrated a higher sensitivity of the molecular method in detecting bacterial pathogens. The increased sensitivity of PCR may be attributed, at least in part, to the fact that PCR does not depend on bacterial viability. This is of special importance for fastidious otopathogens like S. pneumoniae and H. influenzae. Our results corresponded to an earlier report demonstrating that, in patients with otitis media, PCR was more sensitive than the conventional culture method in detecting MEF H. influenzae by at least 5 times (Ueyama et al., 1995) . Another explanation for culture negative/PCR-positive results could be the presence of nonculturable bacteria remaining in MEF after previous AOM episode (Palmu et al., 2004) . However, nonviable bacteria or DNA from dead bacteria may reside in the MEF no longer than a few days, being efficiently eliminated from the middle ear (Post et al., 1996) . Instead, MEF-detectable DNA may originate from the nasopharynx through a continuous feed of the DNAcontaining media. Moreover, the presence of bacterial biofilms has been proposed as a reason for culture failure but positive PCR results (Ehrlich et al., 2002; Palmu et al., 2004) .
Our PCR analyses did not support the etiological role in AOM for atypical bacteria like M. pneumoniae and Chlamydophila spp., which were not detected in MEF of any patient. This is corroborated by previous reports that never demonstrated the presence of M. pneumoniae in the MEF (Pitkäranta et al., 2006; Rosenblut et al., 2001) and only occasionally found Chlamydophila spp. in AOM patients, mainly during epidemic elevations of its prevalence (Block et al., 1997; Falck et al., 1998) .
Reportedly, the prevalence and distribution of viruses in MEF have not been consistent, varying in different study settings and geographic regions and having seasonal and detection method-dependent fluctuations. In several reports from Finland, detection rate of viruses in the MEF was 48-67%, with the predominance of picornaviruses (hRV and enteroviruses) (Nokso-Koivisto et al., 2004; Pitkäranta et al., 1998; Ruohola et al., 2006) . A study from the United States identified 41% virus-positive AOM patients, of whom 75% had RSV in the MEF (Heikkinen et al., 1999) . In a Turkish report, a respiratory virus was found in MEF of 32.5% AOM patients; RSV and hRV had the highest identification rate (46.5% and 25.6% among virus-positive patients, respectively) (Bulut et al., 2007) . The virus detection rate was much lower in a paper from Japan that identified respiratory viruses in 9.3% of AOM patients by culturing; almost a half of detected viruses were represented by RSV (Yano et al., 2009) . Similar results were observed in a study from Chile, where only 13% of children with AOM had a virus in the MEF (Rosenblut et al., 2001) .
In our patient cohort, only hRV and AdV had a somewhat appreciable representation in the MEF, covering collectively more than 85% (17/26) virus-positive patients. RSV that has been consistently detected as one of the most abundant viruses in MEF (Patel et al., 2007) was found only in 1 patient (in combination with H. influenzae). This finding corresponded to a low incidence of the RSV infection during the study period in Russia that was estimated as 2-10% of all acute respiratory infection visits (Iatsyshina et al., 2013) .
The role of respiratory viruses in development of AOM has been discussed in several interesting papers (Chonmaitree et al., 2012; Heikkinen and Chonmaitree, 2003; Nokso-Koivisto et al., 2015) . Clinically evident ARVI has been shown to associate with increased risk of AOM, involving a wide range of mechanisms. Although the significance of viruses in development of AOM has been suggested in a chinchilla model in vivo (Bakaletz et al., 1993) , their importance as independent etiological agents remains controversial. A viral infection facilitates the passage of bacterial pathogens from the nasopharynx into the middle ear, supporting progression to clinical illness (AOM) (Lieberthal et al., 2013) . Moreover, respiratory viruses, particularly hRV, promote spreading of bacterial agents among the human population and may produce an imbalance of the Nph microbiota enhancing proliferation of S. pneumoniae or H. influenzae there (Heikkinen and Chonmaitree, 2003) . Similarly, our present results do not favor the direct role of respiratory viruses in development of AOM demonstrating, in the majority of patients with AOM, low prevalence of viruses in conjunction with the presence of significant bacterial otopathogens in the MEF or nasopharynx.
Predictive value of PCR results in the nasopharynx for the assessment of MEF
The PPV of Nph specimen examination by PCR discovered a considerable, pathogen-dependent variability. The highest PPV (92%) was found for S. pneumoniae, the most prevalent pathogen. S. aureus and M. catarrhalis demonstrated low PPVs and weak association between MEF and Nph PCR results, having a high proportion of MEF-negative/ Nph-positive results. Remarkably, the S. aureus DNA was always detected in a combination with the other NAs, and the M. catarrhalis DNA was more prevalent in the nasopharynx than in the middle ear. These data may suggest that both species are more likely to colonize the Table 3 The value of PCR results from the nasopharynx in predicting the presence of a pathogen in the middle ear.
Pathogen
Overall in the nasopharynx, n (%) The number of each bacterial pathogen isolate tested is indicated in Table 2 for MEF specimens (the column "PCR positive") and in Table 3 for Nph specimens (the column "Overall in the nasopharynx").
nasopharynx than to serve as the primary cause of clinical infection in the middle ear. Thus, in general, Nph PCR results were more reliable in excluding the presence of a respiratory pathogen NA in the MEF. Consistently high NPVs suggested that, if an Nph PCR result was negative for a particular NA, this NA was unlikely to be detected in MEF of an AOM patient. Of note, the overall concordance of MEF and Nph PCR results, i.e., the proportion of specimens with the same PCR results both in the nasopharynx and MEF, was high (range, 82-98%). However, the diagnostic significance of such an agreement was limited due to a large number of negative concordant results that the least prevalent pathogens, like viruses, had.
Quantitative real-time PCR and multiplex detection of five bacterial species have not been used for assessment of association between MEF and Nph microbiota in AOM patients before. Most studies evaluating concordance between MEF and Nph findings have used conventional culture, whereas PCR was employed in only 2 papers for analysis of a narrow set of species (Eser et al., 2009; Ueyama et al., 1995; van Dongen et al., 2013) . Overall, results reported in the literature demonstrate modest to low PPVs (around 50%) for the most relevant microbes, but moderate to high NPVs, ranging from 68% to 97% (van Dongen et al., 2013) . In the present study, we observed higher PPVs for S. pneumoniae and H. influenzae than has previously been reported, which suggests better performance of the PCR method in predicting MEF findings.
Some limitations of the present study need to be mentioned. First, the patient cohort included children who required tympanocentesis. This may have biased our sample toward a more severe AOM, thus disturbing the pathogen distribution and increasing the proportion of detected bacteria at the expense of viruses. Next, we did not examine patients with spontaneous otorrhea who may have a more aggressive AOM course associated with bacteria like S. pyogenes. Finally, swabbing the tympanic cavity after tympanocentesis could have been less effective comparing to aspiration of the MEF in terms of collecting detectable amount of viral pathogens.
Conclusions
Taken together, our results indicate that multiplex real-time PCR is a reasonable approach for detection of respiratory pathogens in patients with AOM. Using MEF specimens as the reference, we demonstrated that the parallel PCR examination of Nph specimens provided useful information on MEF pathogens that had a high predictive value for excluding a pathogen. Investigation of the Nph microbiota could be a reliable proxy for MEF examination in epidemiological studies and in trials looking for potential benefits of new vaccines for respiratory pathogens. In addition, PCR analysis of Nph specimens could be helpful in predicting bacterial complications during ARVI, for instance, AOM.
In conclusion, further implementation of sensitive, rapid, and multiplexed molecular methods would extend our understanding of the respiratory pathogen interplay and improve diagnostics of respiratory infections.
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